Magnetic Resonance Imaging Markers for Cognitive Impairment in Parkinson’s Disease: Current View

Cognitive impairment (CI) ranging from mild cognitive impairment (MCI) to dementia is a common and disturbing complication in patients with Parkinson’s disease (PD). Numerous studies have focused on neuropathological mechanisms underlying CI in PD, along with the identification of specific biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yanbing, Shang, Huifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821910/
https://www.ncbi.nlm.nih.gov/pubmed/35145396
http://dx.doi.org/10.3389/fnagi.2022.788846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821910/
https://www.ncbi.nlm.nih.gov/pubmed/35145396
http://dx.doi.org/10.3389/fnagi.2022.788846

Ejemplares similares